Masimo Corporation (MASI)
NASDAQ: MASI · IEX Real-Time Price · USD
134.41
-1.79 (-1.31%)
At close: Apr 30, 2024, 4:00 PM
135.00
+0.59 (0.44%)
Pre-market: May 1, 2024, 7:03 AM EDT

Masimo Revenue

In the year 2023, Masimo had annual revenue of $2.05B with 0.60% growth. Revenue in the quarter ending December 30, 2023 was $548.90M, a -11.04% decrease year-over-year.

Revenue (ttm)
$2.05B
Revenue Growth
+0.60%
P/S Ratio
3.47
Revenue / Employee
$538,974
Employees
3,800
Market Cap
7.11B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 30, 20232.05B12.30M0.60%
Dec 31, 20222.04B892.10M78.00%
Jan 1, 20221.14B-44.00K-0.00%
Jan 2, 20211.14B205.91M21.96%
Dec 28, 2019937.84M--
Dec 29, 2018937.84M79.55M9.27%
Dec 30, 2017858.29M145.39M20.39%
Dec 31, 2016712.90M82.79M13.14%
Jan 2, 2016630.11M43.47M7.41%
Jan 3, 2015586.64M39.40M7.20%
Dec 28, 2013547.25M54.01M10.95%
Dec 29, 2012493.23M54.25M12.36%
Dec 31, 2011438.99M33.58M8.28%
Jan 1, 2011405.41M56.29M16.12%
Jan 2, 2010349.12M42.04M13.69%
Jan 3, 2009307.07M50.79M19.82%
Dec 29, 2007256.29M31.95M14.24%
Dec 31, 2006224.34M116.45M107.93%
Dec 31, 2005107.89M38.53M55.56%
Dec 31, 200469.36M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Bio-Rad Laboratories 2.67B
Exelixis 1.83B
Globus Medical 1.57B
Penumbra 1.06B
HealthEquity 999.59M
Inspire Medical Systems 624.80M
Intra-Cellular Therapies 464.37M
Ascendis Pharma 296.35M
Revenue Rankings